238 related articles for article (PubMed ID: 32045393)
1. Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.
Chan JK; Hernandez Martínez de Lapiscina E; Taylor C; Nguyen AL; Alba-Arbalat S; Devonshire V; Sayao AL; Carruthers R; Costello F; Traboulsee A
J Neuroophthalmol; 2020 Mar; 40(1):37-43. PubMed ID: 32045393
[TBL] [Abstract][Full Text] [Related]
2. Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: A retrospective study.
Button J; Al-Louzi O; Lang A; Bhargava P; Newsome SD; Frohman T; Balcer LJ; Frohman EM; Prince J; Calabresi PA; Saidha S
Neurology; 2017 Feb; 88(6):525-532. PubMed ID: 28077493
[TBL] [Abstract][Full Text] [Related]
3. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Saidha S; Syc SB; Durbin MK; Eckstein C; Oakley JD; Meyer SA; Conger A; Frohman TC; Newsome S; Ratchford JN; Frohman EM; Calabresi PA
Mult Scler; 2011 Dec; 17(12):1449-63. PubMed ID: 21865411
[TBL] [Abstract][Full Text] [Related]
4. Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis.
Winges KM; Werner JS; Harvey DJ; Cello KE; Durbin MK; Balcer LJ; Calabresi PA; Keltner JL
J Neuroophthalmol; 2013 Dec; 33(4):322-9. PubMed ID: 24051419
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Glatiramer Acetate on Retinal Nerve Fiber Layer Thickness in Patients with Relapsing-Remitting Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Zivadinov R; Tavazzi E; Hagemeier J; Carl E; Hojnacki D; Kolb C; Weinstock-Guttman B
CNS Drugs; 2018 Aug; 32(8):763-770. PubMed ID: 29767815
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography in multiple sclerosis: A 3-year prospective multicenter study.
Paul F; Calabresi PA; Barkhof F; Green AJ; Kardon R; Sastre-Garriga J; Schippling S; Vermersch P; Saidha S; Gerendas BS; Schmidt-Erfurth U; Agoropoulou C; Zhang Y; Seifer G; Petzold A
Ann Clin Transl Neurol; 2021 Dec; 8(12):2235-2251. PubMed ID: 34792863
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Retinal Atrophy With Rituximab in Multiple Sclerosis.
Lambe J; Risher H; Filippatou AG; Murphy OC; Sotirchos ES; Ehrhardt H; Ogbuokiri E; Pellegrini N; Toliver B; Luciano NJ; Davis S; Fioravante N; Kwakyi O; Prince JL; Calabresi PA; Fitzgerald KC; Saidha S
Neurology; 2021 May; 96(20):e2525-e2533. PubMed ID: 33827962
[TBL] [Abstract][Full Text] [Related]
8. Retinal nerve fiber and ganglion cell complex layer thicknesses mirror brain atrophy in patients with relapsing-remitting multiple sclerosis.
Glasner P; Sabisz A; Chylińska M; Komendziński J; Wyszomirski A; Karaszewski B
Restor Neurol Neurosci; 2022; 40(1):35-42. PubMed ID: 35180139
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of retinal nerve fiber layer thickness changes in a multiple sclerosis patients cohort: A long term 5 year follow-up.
Abalo-Lojo JM; Treus A; Arias M; Gómez-Ulla F; Gonzalez F
Mult Scler Relat Disord; 2018 Jan; 19():124-128. PubMed ID: 29216540
[TBL] [Abstract][Full Text] [Related]
10. Optical coherence tomography segmentation analysis in relapsing remitting versus progressive multiple sclerosis.
Behbehani R; Abu Al-Hassan A; Al-Salahat A; Sriraman D; Oakley JD; Alroughani R
PLoS One; 2017; 12(2):e0172120. PubMed ID: 28192539
[TBL] [Abstract][Full Text] [Related]
11. Early neuroaxonal injury is seen in the acute phase of pediatric optic neuritis.
Wilbur C; Reginald YA; Longoni G; Grover SA; Wong AM; Mabbott DJ; Arnold DL; Marrie RA; Bar-Or A; Banwell B; Costello F; Yeh EA;
Mult Scler Relat Disord; 2019 Nov; 36():101387. PubMed ID: 31539739
[TBL] [Abstract][Full Text] [Related]
12. A prospective study of disease modifying therapy and retinal atrophy in relapsing-remitting multiple sclerosis.
Kabanovski A; Zaslavsky K; Rotstein D; Margolin E
J Neurol Sci; 2023 Mar; 446():120552. PubMed ID: 36774748
[TBL] [Abstract][Full Text] [Related]
13. Inner Retinal Layer Changes Reflect Changes in Ambulation Score in Patients with Primary Progressive Multiple Sclerosis.
Gernert JA; Böhm L; Starck M; Buchka S; Kümpfel T; Kleiter I; Havla J
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629053
[TBL] [Abstract][Full Text] [Related]
14. Interferon-β Is Less Effective Than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MS.
You Y; Barnett MH; Yiannikas C; Parratt JDE; Matthews JG; Graham SL; Klistorner A
Neurol Neuroimmunol Neuroinflamm; 2021 May; 8(3):. PubMed ID: 33597189
[TBL] [Abstract][Full Text] [Related]
15. Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Graham EC; You Y; Yiannikas C; Garrick R; Parratt J; Barnett MH; Klistorner A
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2311-7. PubMed ID: 27127930
[TBL] [Abstract][Full Text] [Related]
16. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
Brown JWL; Coles A; Horakova D; Havrdova E; Izquierdo G; Prat A; Girard M; Duquette P; Trojano M; Lugaresi A; Bergamaschi R; Grammond P; Alroughani R; Hupperts R; McCombe P; Van Pesch V; Sola P; Ferraro D; Grand'Maison F; Terzi M; Lechner-Scott J; Flechter S; Slee M; Shaygannejad V; Pucci E; Granella F; Jokubaitis V; Willis M; Rice C; Scolding N; Wilkins A; Pearson OR; Ziemssen T; Hutchinson M; Harding K; Jones J; McGuigan C; Butzkueven H; Kalincik T; Robertson N;
JAMA; 2019 Jan; 321(2):175-187. PubMed ID: 30644981
[TBL] [Abstract][Full Text] [Related]
17. Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography in different clinical subtypes of multiple sclerosis.
Jankowska-Lech I; Wasyluk J; Palasik W; Terelak-Borys B; Grabska-Liberek I
Mult Scler Relat Disord; 2019 Jan; 27():260-268. PubMed ID: 30423530
[TBL] [Abstract][Full Text] [Related]
18. Baseline retinal nerve fiber layer thickness as a predictor of multiple sclerosis progression: New insights from the FREEDOMS II study.
Wang L; Tan H; Yu J; ZhangBao J; Huang W; Chang X; Zhou L; Lu C; Xiao Y; Lu J; Zhao C; Wang M; Wu X; Wu M; Dong Q; Ngew KY; Quan C
Eur J Neurol; 2023 Feb; 30(2):443-452. PubMed ID: 36286605
[TBL] [Abstract][Full Text] [Related]
19. Axonal Degeneration Independent of Inflammatory Activity: Is It More Intense in the Early Stages of Relapsing-Remitting Multiple Sclerosis Disease?
Cilingir V; Batur M
Eur Neurol; 2020; 83(5):508-516. PubMed ID: 32957101
[TBL] [Abstract][Full Text] [Related]
20. Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis.
Miante S; Margoni M; Moretto M; Pengo M; Carmisciano L; Spolettini P; Silvestri E; Danieletto M; Franciotta S; Miscioscia A; Bertoldo A; Puthenparampil M; Gallo P
Mult Scler Relat Disord; 2023 Sep; 77():104877. PubMed ID: 37454566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
